...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6)
【24h】

Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6)

机译:氧杂双环辛烷连接的1,5-萘吡啶基新型细菌拓扑异构酶抑制剂的吡ido嗪酮取代的RHS类似物作为广谱抗菌剂的结构活性关系(第6部分)

获取原文
获取原文并翻译 | 示例
           

摘要

Oxabicyclooctane linked 1,5-naphthyridinyl-pyridoxazinones are novel broad-spectrum bacterial topoisomerase inhibitors (NBTIs) targeting bacterial DNA gyrase and topoisomerase IV at a site different than quinolones. Due to lack of cross-resistance to known antibiotics they present excellent opportunity to combat drug-resistant bacteria. A structure activity relationship of the pyridoxazinone moiety is described in this Letter. Chemical synthesis and activities of NBTIs with substitutions at C-3, C-4 and C-7 of the pyridoxazinone moiety with halogens, alkyl groups and methoxy group has been described. In addition, substitutions of the linker NH proton and its transformation into amide analogs of AM-8085 and AM-8191 have been reported. Fluoro, chloro, and methyl groups at C-3 of the pyridoxazinone moiety retained the potency and spectrum. In addition, a C-3 fluoro analog showed 4-fold better oral efficacy (ED50 3.9 mg/kg) as compared to the parent AM-8085 in a murine bacteremia model of infection of Staphylococcus aureus. Even modest polarity (e.g., methoxy) is not tolerated at C-3 of the pyridoxazinone unit. The basicity and NH group of the linker is important for the activity when CH2 is at the linker position-8. However, amides (with linker position-8 ketone) with a position-7 NH or N-methyl group retained potency and spectrum suggesting that neither basicity nor hydrogen-donor properties of the linker amide NH is essential for the activity. This would suggest likely an altered binding mode of the linker position-7,8 amide containing compounds. The amides showed highly improved hERG (functional IC50 > 30 mu M) profile. (C) 2015 Elsevier Ltd. All rights reserved.
机译:氧杂双环辛烷连接的1,5-萘啶基-吡啶并恶嗪酮是新型广谱细菌拓扑异构酶抑制剂(NBTI),其靶向细菌DNA促旋酶和拓扑异构酶IV的位置不同于喹诺酮。由于对已知抗生素缺乏交叉耐药性,因此它们提供了抵抗耐药细菌的绝好机会。吡ido嗪酮部分的结构活性关系在该信中描述。已经描述了在吡啶并嗪嗪酮部分的C-3,C-4和C-7处被卤素,烷基和甲氧基取代的NBTI的化学合成和活性。另外,已经报道了连接子NH质子的取代及其向AM-8085和AM-8191的酰胺类似物的转化。吡ido并嗪酮部分的C-3处的氟,氯和甲基基团保留了效力和光谱。此外,在感染金黄色葡萄球菌的鼠菌血症模型中,C-3氟类似物的口服功效(母体AM-8085)比口服AM-8085好4倍(ED50 3.9 mg / kg)。吡ido并嗪酮单元的C-3甚至不容许中等极性(例如甲氧基)。当CH2在8位连接基上时,连接基的碱性和NH基团对于活性至关重要。但是,具有7位NH或N-甲基基团的酰胺(具有8位连接基的酮)保留了效能和光谱,这表明该连接基酰胺NH的碱性和氢供体性质都不是活性所必需的。这将暗示可能改变了含有7,8位酰胺的接头位置的结合模式。酰胺显示出高度改善的hERG(功能性IC50> 30μM)曲线。 (C)2015 Elsevier Ltd.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号